These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 21147628)
1. Modulation of peripheral chemoreflex by neurohumoral adaptations after kidney transplantation. Rassaf T; Westenfeld R; Balzer J; Lauer T; Merx M; Floege J; Steiner S; Heiss C; Kelm M; Meyer C Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):83-7. PubMed ID: 21147628 [TBL] [Abstract][Full Text] [Related]
2. Sympathetic hyperactivity influences chemosensor function in patients with end-stage renal disease. Meyer C; Schueller P; Balzer J; Lauer T; Westenfeld R; Schauerte P; Hennersdorf M; Steiner S; Kelm M; Rassaf T Eur J Med Res; 2009 Dec; 14 Suppl 4(Suppl 4):151-5. PubMed ID: 20156747 [TBL] [Abstract][Full Text] [Related]
3. Peripheral chemosensor function is blunted in moderate to severe chronic kidney disease. Rassaf T; Schueller P; Westenfeld R; Floege J; Eickholt C; Hennersdorf M; Merx MW; Schauerte P; Kelm M; Meyer C Int J Cardiol; 2012 Mar; 155(2):201-5. PubMed ID: 20980069 [TBL] [Abstract][Full Text] [Related]
4. Respiratory and heart rate dynamics during peripheral chemoreceptor deactivation compared to targeted sympathetic and sympathetic/parasympathetic (co-)activation. Apelt-Glitz K; Alken FA; Jungen C; Scherschel K; Klöcker N; Meyer C Auton Neurosci; 2022 Sep; 241():103009. PubMed ID: 35753247 [TBL] [Abstract][Full Text] [Related]
5. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. Sun SY; Wang W; Zucker IH; Schultz HD J Appl Physiol (1985); 1999 Apr; 86(4):1264-72. PubMed ID: 10194212 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous assessment of central and peripheral chemoreflex regulation of muscle sympathetic nerve activity and ventilation in healthy young men. Keir DA; Duffin J; Millar PJ; Floras JS J Physiol; 2019 Jul; 597(13):3281-3296. PubMed ID: 31087324 [TBL] [Abstract][Full Text] [Related]
8. Tonic chemoreflex activation contributes to the elevated muscle sympathetic nerve activity in patients with chronic renal failure. Hering D; Zdrojewski Z; Król E; Kara T; Kucharska W; Somers VK; Rutkowski B; Narkiewicz K J Hypertens; 2007 Jan; 25(1):157-61. PubMed ID: 17143187 [TBL] [Abstract][Full Text] [Related]
9. Sympathetic nerve activity in end-stage renal disease. Hausberg M; Kosch M; Harmelink P; Barenbrock M; Hohage H; Kisters K; Dietl KH; Rahn KH Circulation; 2002 Oct; 106(15):1974-9. PubMed ID: 12370222 [TBL] [Abstract][Full Text] [Related]
10. Tonic chemoreflex activation does not contribute to elevated muscle sympathetic nerve activity in heart failure. van de Borne P; Oren R; Anderson EA; Mark AL; Somers VK Circulation; 1996 Sep; 94(6):1325-8. PubMed ID: 8822987 [TBL] [Abstract][Full Text] [Related]
11. Peripheral chemoreflex activation contributes to sympathetic baroreflex impairment in chronic heart failure. Despas F; Lambert E; Vaccaro A; Labrunee M; Franchitto N; Lebrin M; Galinier M; Senard JM; Lambert G; Esler M; Pathak A J Hypertens; 2012 Apr; 30(4):753-60. PubMed ID: 22241144 [TBL] [Abstract][Full Text] [Related]